1. Home
  2. AFYA vs SYRE Comparison

AFYA vs SYRE Comparison

Compare AFYA & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFYA
  • SYRE
  • Stock Information
  • Founded
  • AFYA 1999
  • SYRE 2013
  • Country
  • AFYA Brazil
  • SYRE United States
  • Employees
  • AFYA N/A
  • SYRE N/A
  • Industry
  • AFYA Other Consumer Services
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • AFYA Real Estate
  • SYRE Health Care
  • Exchange
  • AFYA Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • AFYA 1.5B
  • SYRE 1.3B
  • IPO Year
  • AFYA 2019
  • SYRE 2016
  • Fundamental
  • Price
  • AFYA $17.35
  • SYRE $21.29
  • Analyst Decision
  • AFYA Sell
  • SYRE Strong Buy
  • Analyst Count
  • AFYA 5
  • SYRE 8
  • Target Price
  • AFYA $18.00
  • SYRE $51.50
  • AVG Volume (30 Days)
  • AFYA 110.2K
  • SYRE 574.3K
  • Earning Date
  • AFYA 03-13-2025
  • SYRE 03-03-2025
  • Dividend Yield
  • AFYA N/A
  • SYRE N/A
  • EPS Growth
  • AFYA 62.61
  • SYRE N/A
  • EPS
  • AFYA 1.17
  • SYRE N/A
  • Revenue
  • AFYA $584,951,886.00
  • SYRE N/A
  • Revenue This Year
  • AFYA $17.42
  • SYRE $168.62
  • Revenue Next Year
  • AFYA $12.85
  • SYRE $47.61
  • P/E Ratio
  • AFYA $14.82
  • SYRE N/A
  • Revenue Growth
  • AFYA 16.67
  • SYRE N/A
  • 52 Week Low
  • AFYA $14.52
  • SYRE $20.13
  • 52 Week High
  • AFYA $22.24
  • SYRE $47.97
  • Technical
  • Relative Strength Index (RSI)
  • AFYA 59.58
  • SYRE 40.66
  • Support Level
  • AFYA $16.55
  • SYRE $21.61
  • Resistance Level
  • AFYA $18.05
  • SYRE $23.04
  • Average True Range (ATR)
  • AFYA 0.43
  • SYRE 1.43
  • MACD
  • AFYA 0.08
  • SYRE -0.03
  • Stochastic Oscillator
  • AFYA 70.71
  • SYRE 22.03

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.

Share on Social Networks: